Latest filing published 01 May 2026 for Vericel Corp.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +74.1%Entry US$11.10 · Close at T+365 US$19.33
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Alan L. Rubino: trading record in brief
Filings by Alan L. Rubino span 2 companies, the busiest being Vericel Corp and Pharmos Corp. Over a trading history stretching from 22 May 2006 to 29 April 2026, the count stands at 17 filings.
The open-market record is one-sided, with 4 purchases worth €10k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 13 option exercises.
In size, the median ticket on the buying side is €1,601. None of the 3 purchases we analysed coincided with buying by another insider of the same company within 30 days. After 3 purchases with a full 90-day history, the hit rate stands at 100% and the median 90-day move at +9.0%. They describe history only and say nothing certain about the share price ahead.
Most recently, on 1 May 2026, the filings show an option exercise in Vericel Corp. The last purchase on record was published on 20 March 2018, which is 3,155 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Alan L. Rubino
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,200 sharesCommon StockSEC:0001140361-26-018540:0
- 15,000 shares@ US$2.7639.4% of flowCommon StockSEC:0001140361-26-011730:0
- 3,200 sharesCommon StockSEC:0001140361-25-017113:0
- 15,000 shares@ US$3.7415.8% of flowCommon StockSEC:0001140361-25-003834:1
- 4,000 shares@ US$3.7415.9% of flowCommon StockSEC:0001140361-25-003834:0
- 3,200 sharesCommon StockSEC:0001140361-24-024329:0
- 3,000 shares@ US$4.1212.6% of flowCommon StockSEC:0001140361-24-019357:0
- 2,600 sharesCommon StockSEC:0001140361-23-021497:0
- 3,000 shares@ US$10.6032.0% of flowCommon StockSEC:0001140361-23-020911:0
- 2,600 sharesCommon StockSEC:0001593968-22-000889:0
- 1,750 sharesCommon StockSEC:0001593968-21-001211:0
- 5,000 shares@ US$45.2065.8% of flowCommon StockSEC:0001593968-21-000988:0
- 1,750 shares0Common StockSEC:0001593968-20-001085:0
- 165 shares@ US$11.581.6% of flowCommon StockSEC:0001593968-18-000609:0Canonical exit: 14 Jun 2018 (T+90)
- 685 shares@ US$11.576.5% of flowCommon StockSEC:0001593968-18-000609:1Canonical exit: 14 Jun 2018 (T+90)
- 40 shares@ US$11.500.4% of flowCommon StockSEC:0001593968-18-000609:2Canonical exit: 14 Jun 2018 (T+90)
- 1,000 shares@ US$2.11common stockSEC:0001331868-06-000003:0Canonical exit: 20 Aug 2006 (T+90)
17 of 17 declarations
